Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02181 MABPHARM-B
RT Nominal unchange0.475 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others485,010-5.091%511,024551,753615,232636,306
Land & other Lease Assets56,706-2.179%57,96962,49271,30467,707
Intangible Assets139,80045.238%96,25633,34500
Interests in Asso. & JCEs0--0000
Other Non-current Assets65,31421.152%53,9112,8546,23112,388

746,8303.848%719,160650,444692,767716,401
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories145,0146.188%136,564111,009102,037100,797
Trade Receivables150,468-2.961%155,05994,52619,4239,532
Cash & Bank Balances93,328-14.580%109,25889,344173,34533,568
Other Current Assets32,982-1.308%33,41970,89547,40157,223
Assets Held for Sale0--0000

421,792-2.880%434,300365,774342,206201,120
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables41,20236.580%30,16711,70910,01216,586
S-T Debt & Leases157,541-32.596%233,72697,261125,25813,291
Other Current Liabilities304,84612.843%270,151203,155180,921158,524
Liab asso w/ Assets Held for Sale0--0000

503,589-5.703%534,044312,125316,191188,401
Net Current Assets(81,797)-17.993%(99,744)53,64926,01512,719
Total Assets Less Current Liabilities665,0337.365%619,416704,093718,782729,120
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases150,39561.692%93,013195,831134,815113,046
Other Non-current Liabilities320,801-13.085%369,099419,328378,910215,130

471,1961.966%462,112615,159513,725328,176
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital2,8040.000%2,8042,8042,8042,804
  Reserves191,03323.646%154,50086,130202,253398,140
  Others0--0000
Shareholders' Funds193,83723.224%157,30488,934205,057400,944
Non-controlling Interests0--0000
Others0--0000

193,83723.224%157,30488,934205,057400,944
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments------4,2233,97820,760
Contingent Liabilities------000
Remarks:  Real time quote last updated: 10/09/2026 12:30
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 31,360
%Change982.126%
EPS / (LPS)RMB 0.010
NBV Per Share (¥)RMB 0.047
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.